Yellow fever vaccine, YF-VAX, out-of-stock: FDA to allow use of Stamaril

In a follow-up to a CDC report from April, stocks of the only yellow fever vaccine licensed in the United States have been depleted, prompting the Food and Drug Administration to allow the use of an unlicensed yellow fever vaccine. Last Monday, Sanofi Pasteur, the manufacturer of YF-VAX said their stock of the vaccine is totally depleted and will be unavailable ["]

The post Yellow fever vaccine, YF-VAX, out-of-stock: FDA to allow use of Stamaril appeared first on Outbreak News Today.